SENTER FOR REGENERATIV MEDISIN AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−85k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−334k kr).
SENTER FOR REGENERATIV MEDISIN AS is registered as a limited company in Oslo, Oslo with organisation number 933773620. The business is classified under other health services (NACE 86.993). The company was incorporated in 2024. Registered share capital is NOK 250,000, divided into 8334 shares. The company's stated purpose is: “Tilby helsemessige og medisinske regenerative tjenester gjennom drift og veiledning av regenerative medisinske klinikker.”. The most recent filed accounts, for the 2025 financial year, show NOK 43,000 in revenue and NOK −334,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns SENTER FOR REGENERATIV MEDISIN AS?
SENTER FOR REGENERATIV MEDISIN AS has 3 registered shareholders:
- ØRNULF JENSSEN 50.0%
- MED DYNAMICS AS 30.0%
- KJELL DAGFINN BRAATHEN 20.0%
Frequently asked questions about SENTER FOR REGENERATIV MEDISIN AS
Who owns SENTER FOR REGENERATIV MEDISIN AS?
ØRNULF JENSSEN is the largest registered owner, with 50.0%.
What is the revenue of SENTER FOR REGENERATIV MEDISIN AS?
SENTER FOR REGENERATIV MEDISIN AS had revenue of NOK 43,000 in 2025.
Who is the general manager of SENTER FOR REGENERATIV MEDISIN AS?
Ole Petter Braathen is registered as general manager of SENTER FOR REGENERATIV MEDISIN AS.
Where is SENTER FOR REGENERATIV MEDISIN AS based?
SENTER FOR REGENERATIV MEDISIN AS has its business address in Oslo.
Property
117 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.